Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 414Unknown 163Recruiting 114Terminated 102Active not recruiting 48Withdrawn 38Not yet recruiting 35Enrolling by invitation 4Suspended 2

Sponsor Class

OTHER 3FED 1

Study Type

Observational 5Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Neoplasms 40Breast Neoplasms 40Prostatic Neoplasms 24Colorectal Neoplasms 24Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 14Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Lung Neoplasms 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Ovarian Neoplasms 6Epilepsy 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Dementia 5Cholangiocarcinoma 5Recurrence 4

Interventions

lenvatinib 1Patient Navigation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Liver Neoplasms × Clear all
NCT07537205 2026-04-17

The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol

Fudan University

Phase NA Enrolling by invitation
92 enrolled
Gastrointestinal

Liver Neoplasms

NCT06458998 2026-02-23

GTI

University of Pittsburgh

Phase NA Enrolling by invitation
30,300 enrolled
Gastrointestinal

Colonic Neoplasms, Fibrosis, Liver Neoplasms

NCT06061328 2026-02-04

OASIS

VA Office of Research and Development

Phase NA Enrolling by invitation
8,020 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05171335 2022-09-21

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

The Methodist Hospital Research Institute

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡